Search results
Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors
Zacks via Yahoo Finance· 1 day agoThe investment community will be paying close attention to the earnings performance of Recursion ...
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical...
Morningstar· 3 days ago...or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug Research (CHDR), will present its Phase 1 stroke study...
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA...
FOX 4 Kansas City· 4 days ago"We look forward to future cases that may resolve these issues for the benefit of innovators, patients and public health."
Recce Pharmaceuticals R327 approved for increase to 4,000mg IV over a fast infusion of 30 minutes
Proactive Investors· 21 hours agoThe Independent Safety Committee has approved an increase of Recce Pharmaceuticals Ltd (ASX:RCE,...
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors
Zacks via Yahoo Finance· 1 day agoAdditionally, investors should keep an eye on any recent revisions to analyst forecasts for NRx ...
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing
WTRF Wheeling· 4 days agoBrise Pharmaceuticals Co., LTD. (Brise), a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A ...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 18 hours agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents By Reuters
Investing.com· 5 days agoThe justices turned away Vanda's appeal of a lower court's ruling against the company, which in 2018...
How 'Megatrends' Like Weight-Loss Drugs And Smartwatches Are Bolstering ResMed
Investor's Business Daily· 13 hours agoIn February, the Food and Drug Administration authorized Samsung's Galaxy watch to detect signs of...
Analyst Report: Evotec SE
Morningstar Research via Yahoo Finance· 19 hours agoEvotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit ...